Lawrence H. Boise - Publications

University of Miami, Coral Gables, FL 
Cell Biology

60 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2016 Deng J, Park D, Wang M, Nooka A, Deng Q, Matulis S, Kaufman J, Lonial S, Boise LH, Galipeau J, Deng X. BCL2-BH4 antagonist BDA-366 suppresses human myeloma growth. Oncotarget. PMID 27049723 DOI: 10.18632/Oncotarget.8513  0.64
2016 Kowalski J, Dwivedi B, Newman S, Switchenko JM, Pauly R, Gutman DA, Arora J, Gandhi K, Ainslie K, Doho G, Qin Z, Moreno CS, Rossi MR, Vertino PM, Lonial S, ... ... Boise LH, et al. Gene integrated set profile analysis: a context-based approach for inferring biological endpoints. Nucleic Acids Research. PMID 26826710 DOI: 10.1093/Nar/Gkv1503  0.64
2015 Stice S, Liu G, Matulis S, Boise LH, Cai Y. Determination of multiple human arsenic metabolites employing high performance liquid chromatography inductively coupled plasma mass spectrometry. Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences. 1009: 55-65. PMID 26708625 DOI: 10.1016/J.Jchromb.2015.12.008  0.64
2015 Matulis SM, Gupta VA, Nooka AK, Von Hollen H, Kaufman JL, Lonial S, Boise LH. Dexamethasone treatment promotes Bcl-2-dependence in multiple myeloma resulting in sensitivity to Venetoclax. Leukemia. PMID 26707935 DOI: 10.1038/Leu.2015.350  0.64
2015 Bajpai R, Matulis SM, Wei C, Nooka AK, Von Hollen HE, Lonial S, Boise LH, Shanmugam M. Targeting glutamine metabolism in multiple myeloma enhances BIM binding to BCL-2 eliciting synthetic lethality to venetoclax. Oncogene. PMID 26640142 DOI: 10.1038/Onc.2015.464  0.64
2015 Lonial S, Boise LH, Kaufman J. How I treat high-risk myeloma Blood. 126: 1536-1543. PMID 26272217 DOI: 10.1182/Blood-2015-06-653261  0.64
2015 Shah SP, Lonial S, Boise LH. When Cancer Fights Back: Multiple Myeloma, Proteasome Inhibition, and the Heat Shock Response. Molecular Cancer Research : McR. PMID 26013169 DOI: 10.1158/1541-7786.Mcr-15-0135  0.64
2015 Gaudette BT, Dwivedi B, Chitta KS, Poulain S, Powell D, Vertino P, Leleu X, Lonial S, Chanan-Khan AA, Kowalski J, Boise LH. Low expression of pro-apoptotic Bcl-2 family proteins sets the apoptotic threshold in Waldenström macroglobulinemia. Oncogene. PMID 25893290 DOI: 10.1038/Onc.2015.103  0.64
2015 Rozanski CH, Utley A, Carlson LM, Farren MR, Murray M, Russell LM, Nair JR, Yang Z, Brady W, Garrett-Sinha LA, Schoenberger SP, Green JM, Boise LH, Lee KP. CD28 Promotes Plasma Cell Survival, Sustained Antibody Responses, and BLIMP-1 Upregulation through Its Distal PYAP Proline Motif. Journal of Immunology (Baltimore, Md. : 1950). 194: 4717-28. PMID 25833397 DOI: 10.4049/Jimmunol.1402260  0.64
2015 Ramachandiran S, Adon A, Guo X, Wang Y, Wang H, Chen Z, Kowalski J, Sunay UR, Young AN, Brown T, Mar JC, Du Y, Fu H, Mann KP, Natkunam Y, ... Boise LH, et al. Chromosome instability in diffuse large B cell lymphomas is suppressed by activation of the noncanonical NF-κB pathway. International Journal of Cancer. Journal International Du Cancer. 136: 2341-51. PMID 25359525 DOI: 10.1002/Ijc.29301  0.64
2014 Yang R, Chen L, Newman S, Gandhi K, Doho G, Moreno CS, Vertino PM, Bernal-Mizarchi L, Lonial S, Boise LH, Rossi M, Kowalski J, Qin ZS. Integrated analysis of whole-genome paired-end and mate-pair sequencing data for identifying genomic structural variations in multiple myeloma. Cancer Informatics. 13: 49-53. PMID 25288879 DOI: 10.4137/Cin.S13783  0.64
2014 Wijesinghe DS, Brentnall M, Mietla JA, Hoeferlin LA, Diegelmann RF, Boise LH, Chalfant CE. Ceramide kinase is required for a normal eicosanoid response and the subsequent orderly migration of fibroblasts. Journal of Lipid Research. 55: 1298-1309. PMID 24823941 DOI: 10.1194/Jlr.M048207  0.64
2014 Murray ME, Gavile CM, Nair JR, Koorella C, Carlson LM, Buac D, Utley A, Chesi M, Bergsagel PL, Boise LH, Lee KP. CD28-mediated pro-survival signaling induces chemotherapeutic resistance in multiple myeloma. Blood. 123: 3770-9. PMID 24782505 DOI: 10.1182/Blood-2013-10-530964  0.64
2014 Gu Y, Kaufman JL, Bernal L, Torre C, Matulis SM, Harvey RD, Chen J, Sun SY, Boise LH, Lonial S. MLN4924, an NAE inhibitor, suppresses AKT and mTOR signaling via upregulation of REDD1 in human myeloma cells. Blood. 123: 3269-76. PMID 24713927 DOI: 10.1182/Blood-2013-08-521914  0.64
2014 Brentnall M, Weir DB, Rongvaux A, Marcus AI, Boise LH. Procaspase-3 regulates fibronectin secretion and influences adhesion, migration and survival independently of catalytic function. Journal of Cell Science. 127: 2217-26. PMID 24610949 DOI: 10.1242/Jcs.135137  0.36
2014 Nooka AK, Kaufman JL, Muppidi S, Langston A, Heffner LT, Gleason C, Casbourne D, Saxe D, Boise LH, Lonial S. Consolidation and maintenance therapy with lenalidomide, bortezomib and dexamethasone (RVD) in high-risk myeloma patients Leukemia. 28: 690-693. PMID 24220275 DOI: 10.1038/leu.2013.335  0.64
2014 Brentnall M, Weir DB, Rongvaux A, Marcus AI, Boise LH. Procaspase-3 regulates fibronectin secretion and influences adhesion, migration and survival independently of catalytic function Journal of Cell Science. 127: 2217-2226. DOI: 10.1242/jcs.135137  0.64
2013 Nooka AK, Kaufman JL, Behera M, Langston A, Waller EK, Flowers CR, Gleason C, Boise LH, Lonial S. Bortezomib-containing induction regimens in transplant-eligible myeloma patients: a meta-analysis of phase 3 randomized clinical trials. Cancer. 119: 4119-28. PMID 24005889 DOI: 10.1002/Cncr.28325  0.64
2013 Brentnall M, Rodriguez-Menocal L, De Guevara RL, Cepero E, Boise LH. Caspase-9, caspase-3 and caspase-7 have distinct roles during intrinsic apoptosis. Bmc Cell Biology. 14: 32. PMID 23834359 DOI: 10.1186/1471-2121-14-32  0.68
2012 Ramachandiran S, Cain J, Liao A, He Y, Guo X, Boise LH, Fu H, Ratner L, Khoury HJ, Bernal-Mizrachi L. The Smac mimetic RMT5265.2HCL induces apoptosis in EBV and HTLV-I associated lymphoma cells by inhibiting XIAP and promoting the mitochondrial release of cytochrome C and Smac. Leukemia Research. 36: 784-90. PMID 22325366 DOI: 10.1016/J.Leukres.2011.12.024  0.64
2012 Mannava S, Zhuang D, Nair JR, Bansal R, Wawrzyniak JA, Zucker SN, Fink EE, Moparthy KC, Hu Q, Liu S, Boise LH, Lee KP, Nikiforov MA. KLF9 is a novel transcriptional regulator of bortezomib- and LBH589-induced apoptosis in multiple myeloma cells. Blood. 119: 1450-8. PMID 22144178 DOI: 10.1182/Blood-2011-04-346676  0.64
2011 Neri P, Ren L, Gratton K, Stebner E, Johnson J, Klimowicz A, Duggan P, Tassone P, Mansoor A, Stewart DA, Lonial S, Boise LH, Bahlis NJ. Bortezomib-induced "BRCAness" sensitizes multiple myeloma cells to PARP inhibitors. Blood. 118: 6368-79. PMID 21917757 DOI: 10.1182/Blood-2011-06-363911  0.64
2011 Rozanski CH, Arens R, Carlson LM, Nair J, Boise LH, Chanan-Khan AA, Schoenberger SP, Lee KP. Sustained antibody responses depend on CD28 function in bone marrow-resident plasma cells. The Journal of Experimental Medicine. 208: 1435-46. PMID 21690252 DOI: 10.1084/Jem.20110040  0.64
2011 Morales AA, Kurtoglu M, Matulis SM, Liu J, Siefker D, Gutman DM, Kaufman JL, Lee KP, Lonial S, Boise LH. Distribution of Bim determines Mcl-1 dependence or codependence with Bcl-xL/Bcl-2 in Mcl-1-expressing myeloma cells. Blood. 118: 1329-39. PMID 21659544 DOI: 10.1182/Blood-2011-01-327197  0.64
2011 Neri P, Ren L, Azab AK, Brentnall M, Gratton K, Klimowicz AC, Lin C, Duggan P, Tassone P, Mansoor A, Stewart DA, Boise LH, Ghobrial IM, Bahlis NJ. Integrin β7-mediated regulation of multiple myeloma cell adhesion, migration, and invasion. Blood. 117: 6202-13. PMID 21474670 DOI: 10.1182/Blood-2010-06-292243  0.64
2010 Boise LH, Minn AJ, Noel PJ, June CH, Accavitti MA, Lindsten T, Thompson CB. CD28 costimulation can promote T cell survival by enhancing the expression of Bcl-xL. Immunity. 1995. 3: 87-98. Journal of Immunology (Baltimore, Md. : 1950). 185: 3788-99. PMID 20858890  0.64
2010 David E, Kaufman JL, Flowers CR, Schafer-Hales K, Torre C, Chen J, Marcus AI, Sun SY, Boise LH, Lonial S. Tipifarnib sensitizes cells to proteasome inhibition by blocking degradation of bortezomib-induced aggresomes. Blood. 116: 5285-8. PMID 20844234 DOI: 10.1182/Blood-2010-03-272393  0.64
2010 Kurtoglu M, Philips K, Liu H, Boise LH, Lampidis TJ. High endoplasmic reticulum activity renders multiple myeloma cells hypersensitive to mitochondrial inhibitors. Cancer Chemotherapy and Pharmacology. 66: 129-40. PMID 19779717 DOI: 10.1007/S00280-009-1143-1  0.64
2007 Vempati UD, Diaz F, Barrientos A, Narisawa S, Mian AM, Millán JL, Boise LH, Moraes CT. Role of cytochrome C in apoptosis: increased sensitivity to tumor necrosis factor alpha is associated with respiratory defects but not with lack of cytochrome C release. Molecular and Cellular Biology. 27: 1771-83. PMID 17210651 DOI: 10.1128/Mcb.00287-06  0.64
2006 Obeng EA, Carlson LM, Gutman DM, Harrington WJ, Lee KP, Boise LH. Proteasome inhibitors induce a terminal unfolded protein response in multiple myeloma cells. Blood. 107: 4907-16. PMID 16507771 DOI: 10.1182/Blood-2005-08-3531  0.76
2005 Cejas PJ, Carlson LM, Kolonias D, Zhang J, Lindner I, Billadeau DD, Boise LH, Lee KP. Regulation of RelB expression during the initiation of dendritic cell differentiation. Molecular and Cellular Biology. 25: 7900-16. PMID 16107733 DOI: 10.1128/Mcb.25.17.7900-7916.2005  0.64
2005 Bahlis NJ, Miao Y, Koc ON, Lee K, Boise LH, Gerson SL. N-benzoylstaurosporine (PKC412) inhibits Akt kinase inducing apoptosis in multiple myeloma cells. Leukemia & Lymphoma. 46: 899-908. PMID 16019536 DOI: 10.1080/10428190500080595  0.64
2005 Cepero E, King AM, Coffey LM, Perez RG, Boise LH. Caspase-9 and effector caspases have sequential and distinct effects on mitochondria. Oncogene. 24: 6354-66. PMID 16007191 DOI: 10.1038/Sj.Onc.1208793  0.64
2005 Obeng EA, Boise LH. Caspase-12 and caspase-4 are not required for caspase-dependent endoplasmic reticulum stress-induced apoptosis. The Journal of Biological Chemistry. 280: 29578-87. PMID 15975932 DOI: 10.1074/Jbc.M502685200  0.76
2005 Cejas PJ, Carlson LM, Zhang J, Padmanabhan S, Kolonias D, Lindner I, Haley S, Boise LH, Lee KP. Protein kinase C betaII plays an essential role in dendritic cell differentiation and autoregulates its own expression. The Journal of Biological Chemistry. 280: 28412-23. PMID 15917249 DOI: 10.1074/Jbc.M500345200  0.64
2004 Wilkinson JC, Cepero E, Boise LH, Duckett CS. Upstream regulatory role for XIAP in receptor-mediated apoptosis Molecular and Cellular Biology. 24: 7003-7014. PMID 15282301 DOI: 10.1128/Mcb.24.16.7003-7014.2004  0.64
2004 Beaupre DM, Cepero E, Obeng EA, Boise LH, Lichtenheld MG. R115777 induces Ras-independent apoptosis of myeloma cells via multiple intrinsic pathways. Molecular Cancer Therapeutics. 3: 179-86. PMID 14985458  0.76
2003 Beaupre DM, McCafferty-Grad J, Bahlis NJ, Boise LH, Lichtenheld MG. Farnesyl transferase inhibitors enhance death receptor signals and induce apoptosis in multiple myeloma cells. Leukemia & Lymphoma. 44: 2123-34. PMID 14959858 DOI: 10.1080/1042819031000116652  0.36
2003 Ghosh SK, Wood C, Boise LH, Mian AM, Deyev VV, Feuer G, Toomey NL, Shank NC, Cabral L, Barber GN, Harrington WJ. Potentiation of TRAIL-induced apoptosis in primary effusion lymphoma through azidothymidine-mediated inhibition of NF-kappa B. Blood. 101: 2321-7. PMID 12406882 DOI: 10.1182/Blood-2002-08-2525  0.64
2001 Grad JM, Bahlis NJ, Boise LH. Ascorbic Acid Augments Arsenic-Mediated Cell Death in Multiple Myeloma (MM) Cells. Thescientificworldjournal. 1: 110. PMID 30147593 DOI: 10.1100/Tsw.2001.123  0.64
2001 Johnson BW, Cepero E, Boise LH. Conversion from a Type I to a Type II Death Receptor-Mediated Pathway through A Partial Inhibition of Caspase-8. Thescientificworldjournal. 1: 98. PMID 30147577 DOI: 10.1100/Tsw.2001.209  0.68
2001 Cepero E, Johnson BW, Boise LH. Mitochondrial Depolarization During TNF-induced Apoptosis is Caspase-dependent and Independent of Bcl-x L and the Permeability Transition Pore. Thescientificworldjournal. 1: 60. PMID 30147531 DOI: 10.1100/Tsw.2001.180  0.68
2001 Toomey NL, Deyev VV, Wood C, Boise LH, Scott D, Liu LH, Cabral L, Podack ER, Barber GN, Harrington WJ. Induction of a TRAIL mediated suicide program by interferon alpha in primary effusion lymphoma Oncogene. 20: 7029-7040. PMID 11704827 DOI: 10.1038/Sj.Onc.1204895  0.64
2001 Grad JM, Cepero E, Boise LH. Mitochondria as targets for established and novel anti-cancer agents. Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy. 4: 85-91. PMID 11512525 DOI: 10.1054/Drup.2001.0192  0.68
2001 Grad JM, Bahlis NJ, Reis I, Oshiro MM, Dalton WS, Boise LH. Ascorbic acid enhances arsenic trioxide-induced cytotoxicity in multiple myeloma cells. Blood. 98: 805-13. PMID 11468182 DOI: 10.1182/Blood.V98.3.805  0.64
2001 Cepero E, Johnson BW, Boise LH. Cloning and analysis of Bcl-2 family genes Methods in Cell Biology. 29-47. PMID 11396008 DOI: 10.1016/S0091-679X(01)66003-5  0.64
2001 Boise LH, Collins CM. Salmonella-induced cell death: Apoptosis, necrosis or programmed cell death? Trends in Microbiology. 9: 64-67. PMID 11173244 DOI: 10.1016/S0966-842X(00)01937-5  0.64
2000 Tang L, Boise LH, Dent P, Grant S. Potentiation of 1-β-D-arabinofuranosylcytosine-mediated mitochondrial damage and apoptosis in human leukemia cells (U937) overexpressing Bcl-2 by the kinase inhibitor 7-hydroxystaurosporine (UCN-01) Biochemical Pharmacology. 60: 1445-1456. PMID 11020446 DOI: 10.1016/S0006-2952(00)00463-9  0.64
2000 Johnson BW, Cepero E, Boise LH. Bcl-x(L) inhibits cytochrome c release but not mitochondria depolarization during the activation of multiple death pathways by tumor necrosis factor-α Journal of Biological Chemistry. 275: 31546-31553. PMID 10913120 DOI: 10.1074/Jbc.M001363200  0.64
1999 Johnson BW, Boise LH. Bcl-2 and caspase inhibition cooperate to inhibit tumor necrosis factor- α-induced cell death in a bcl-2 cleavage-independent fashion Journal of Biological Chemistry. 274: 18552-18558. PMID 10373464 DOI: 10.1074/Jbc.274.26.18552  0.64
1997 Blair PJ, Boise LH, Perfetto SP, Levine BL, McCrary G, Wagner KF, St Louis DC, Thompson CB, Siegel JN, June CH. Impaired induction of the apoptosis-protective protein Bcl-xL in activated PBMC from asymptomatic HIV-infected individuals. Journal of Clinical Immunology. 17: 234-46. PMID 9168404 DOI: 10.1023/A:1027310612323  0.64
1997 Boise LH, Thompson CB. Bcl-x(L) can inhibit apoptosis in cells that have undergone Fas-induced protease activation Proceedings of the National Academy of Sciences of the United States of America. 94: 3759-3764. PMID 9108051 DOI: 10.1073/Pnas.94.8.3759  0.64
1996 Eves EM, Boise LH, Thompson CB, Wagner AJ, Hay N, Rosner MR. Apoptosis induced by differentiation or serum deprivation in an immortalized central nervous system neuronal cell line Journal of Neurochemistry. 67: 1908-1920. PMID 8863495 DOI: 10.1046/J.1471-4159.1996.67051908.X  0.64
1996 Boise LH, Thompson CB. Hierarchical control of lymphocyte survival Science. 274: 67-68. PMID 8848725 DOI: 10.1126/Science.274.5284.67  0.64
1995 Boise LH, Gottschalk AR, Quintans J, Thompson CB. Bcl-2 and Bcl-2-related proteins in apoptosis regulation Current Topics in Microbiology and Immunology. 200: 107-121. PMID 7634826 DOI: 10.1007/978-3-642-79437-7_8  0.64
1995 Choi MSK, Boise LH, Gottschalk AR, Quintans J, Thompson CB, Klaus GGB. The role of bcl-xL in CD40-mediated rescue from anti-μ-induced apoptosis in WEHI-231 B lymphoma cells European Journal of Immunology. 25: 1352-1357. PMID 7539757 DOI: 10.1002/Eji.1830250533  0.64
1994 Wang CY, Bassuk AG, Boise LH, Thompson CB, Bravo R, Leiden JM. Activation of the granulocyte-macrophage colony-stimulating factor promoter in T cells requires cooperative binding of Elf-1 and AP-1 transcription factors. Molecular and Cellular Biology. 14: 1153-9. PMID 8289796  0.64
1994 Gottschalk AR, Boise LH, Thompson CB, Quintáns J. Identification of immunosuppressant-induced apoptosis in a murine B-cell line and its prevention by bcl-x but not bcl-2 Proceedings of the National Academy of Sciences of the United States of America. 91: 7350-7354. PMID 7518929 DOI: 10.1073/Pnas.91.15.7350  0.64
1993 Boise LH, Petryniak B, Mao X, June CH, Wang CY, Lindsten T, Bravo R, Kovary K, Leiden JM, Thompson CB. The NFAT-1 DNA binding complex in activated T cells contains Fra-1 and JunB. Molecular and Cellular Biology. 13: 1911-9. PMID 8441422 DOI: 10.1128/Mcb.13.3.1911  0.64
1992 Ellis AL, Munger CE, Bunch RT, Woods KE, Randolph JK, Boise L, Swerdlow PS, Zwelling LA, Hinds M, Yanovich S. Components of intrinsic drug resistance in the rat hepatoma. Biochemical Pharmacology. 43: 331-42. PMID 1310853 DOI: 10.1016/0006-2952(92)90296-U  0.64
Show low-probability matches.